Skip to Main Content

Paper Details

Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies.
Multiple Sclerosis and Related Disorders
11
2021
Author NameAffiliation
Bruce A C CreeWeill Institute for Neurosciences, University of California san francisco
  • 1 - 1

Datasets

Release 1.2